Printer Friendly

ALAMAR BIOSCIENCES ANNOUNCES ADDITIONAL DISTRIBUTION INTO INTERNATIONAL BIOTECHNOLOGY MARKETS

 SACRAMENTO, Calif., Dec. 6 /PRNewswire/ -- Alamar Biosciences Inc. (NASDAQ: ALMR) announced today that it has signed two non-exclusive distribution agreements for its proprietary research indicator dye, alamarBlue(TM), making it available in Japan and other international markets.
 Wako Pure Chemical Industries Ltd. of Osaka, Japan will sell alamarBlue(TM) in Japan and 32 other countries through a network of sales agents and two subsidiaries, Wako Chemicals USA, of Richmond, Va., and Wako Chemicals Gmbh, of Neuss, Germany. Wako, which employs approximately 1500 people and has consolidated assets of over a half a billion dollars, develops, manufactures and sells chemicals and reagents for the university, medical and industrial markets.
 The second distribution agreement was signed with Astral Scientific Pty. Ltd. which will distribute alamarBlue(TM) in Australia. Astral was established in 1987 as a specialist sales and marketing organization to service clinical and bioresearch markets.
 Kenneth D. Miller, Alamar's chief executive officer, said, "These two additional agreements are a result of our continued efforts to broaden the availability of Alamar products worldwide. alamarBlue(TM) is now available worldwide through these agreements and through an earlier-announced agreement with Biosource International of California, which has 21 international outlets."
 alamarBlue(TM) is a non-toxic indicator dye for use in diagnostic testing of pharmaceutical, cosmetics, household cleaners and hygiene products. In most cases, the indicator dye can be used as a cost effective and safe replacement for MTT, XTT and other common indicator dyes. Sales of alamarBlue(TM) began in late 1992.
 Alamar Biosciences Inc. is a research and development company that develops, manufactures and markets in vitro (outside the body) diagnostic testing products to identify the type of bacteria and antibiotic dosage level in treating bacterial infections, as well as alamarBlue(TM). Alamar's products are available worldwide through a network of distributors and through the company's U.S. sales force. Alamar's common stock is traded on NASDAQ under the symbol ALMR.
 NOTE: For information on Alamar Biosciences Inc. by FAX, dial 1-800-PRO-INFO, extension 141.
 -0- 12/6/93
 /CONTACT: Kenneth D. Miller or Mark L. Santor of Alamar Biosciences, 916-567-3475; or Elizabeth Truax, general information, or Lillian Armstrong, analyst contact, of Financial Relations Board, 415-986-1591, for Alamar Biosciences/
 (ALMR)


CO: Alamar Biosciences Inc.; Wako Pure Chemical Industries Ltd.; Astral
 Scientific Pty. Ltd. ST: California IN: MTC SU:


LW -- SF008 -- 0636 12/06/93 09:09 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 6, 1993
Words:392
Previous Article:SBS ENGINEERING'S ACQUISITION OF IWL COMMUNICATIONS TERMINATED
Next Article:STAAR SURGICAL APPOINTS VICE PRESIDENT OF EUROPEAN AFFAIRS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters